Toggle Main Menu Toggle Search

Open Access padlockePrints

Browsing publications by Professor Michael Barnes.

Newcastle AuthorsTitleYearFull text
Dr Philip Shackley
Dr Lisa Shaw
Dr Christopher Price
Professor Michael Barnes
Dr Laura Graham
et al.
Cost-effectiveness of treating upper limb spasticity due to stroke with botulinum toxin A: results from the botulinum toxin for the upper limb after stroke (BoTULS) trial2012
Professor Michael Barnes
EPID-based verification of the MLC performance for dynamic IMRT and VMAT2012
Dr Lisa Shaw
Dr Christopher Price
Frederike Van Wijck
Dr Philip Shackley
Dr Nick Steen
et al.
Botulinum Toxin for the Upper Limb After Stroke (BoTULS) Trial: Effect on Impairment, Activity Limitation, and Pain2011
Dr Lisa Shaw
Professor Michael Barnes
Emerita Professor Helen Rodgers
Response to Letter by Munin et al Regarding Article, "Botulinum Toxin for the Upper Limb After Stroke (BoTULS) Trial: Effect on Impairment, Activity Limitation, and Pain"2011
Professor Michael Barnes
Developing core sets for persons with traumatic brain injury based on the international classification of functioning, disability, and health2009
Professor Michael Barnes
A systematic review on the diagnosis and treatment of primary (idiopathic) dystonia and dystonia plus syndromes: report of an EFNS/MDS-ES Task Force2006
Professor Michael Barnes
EFNS guideline on diagnosis and management of post-polio syndrome. Report of an EFNS task force2006
Professor Michael Barnes
Sativex (R): clinical efficacy and tolerability in the treatment of symptoms of multiple sclerosis and neuropathic pain2006
Dr Anand Pandyan
Frederike Van Wijck
Professor Garth Johnson
Professor Michael Barnes
The construct validity of a spasticity measurement device for clinical practice: An alternative to the Ashworth scales2006
Professor Michael Barnes
Are changes in self-reported levels of spasticity on a 0-10 Numerical Rating Scale clinically important?2005
Frederike Van Wijck
Professor Michael Barnes
Botulinum toxin and motor learning: enhancing arm function in patients with chronic spasticity2005
Dr Anand Pandyan
Professor Michael Barnes
Frederike Van Wijck
Professor Garth Johnson
Spasticity: Clinical perceptions, neurological realities and meaningful measurement2005
Professor Michael Barnes
The use of botulinum toxin type-B in the treatment of patients who have become unresponsive to botulinum toxin type-A - initial experiences2005
Frederike Van Wijck
Julie Hooper
Professor Michael Barnes
Professor Garth Johnson
[abstract] Improving arm function in patients with chronic spasticity: combining Botulinum Toxin with a task-orientated motor learning programme2004
Jose-de-Jesus Salazar-Torres
Dr Anand Pandyan
Professor Christopher Price
Robert Davidson
Professor Michael Barnes
et al.
Does spasticity result from hyperactive stretch reflexes? Preliminary findings from a stretch reflex characterization study2004
Professor Michael Barnes
What drives quality of life in multiple sclerosis?2004
Dr Anand Pandyan
Dr Christopher Price
Professor Michael Barnes
Professor Garth Johnson
A biomechanical investigation into the validity of the modified ashworth scale as a measure of elbow spasticity2003
Dr Aine Carroll
Professor Michael Barnes
A review of the management of Guillain-Barre syndrome in a regional neurological rehabilitation unit2003
Jose Salazar Torres
Dr Anand Pandyan
Dr Christopher Price
Robert Davidson
Professor Michael Barnes
et al.
Biomechanical Characterization of the Stretch Reflex Activity as an Approach to Spasticity Measurement and Modeling-A pilot study2003
Professor Michael Barnes
Botulinum toxin - Mechanisms of action and clinical use in spasticity2003
Professor Michael Barnes
Community Rehabilitation after Stroke2003
Professor Michael Barnes
Principles of neurological rehabilitation2003
Professor Michael Barnes
Joanna Semlyen
Kate McMullen
Spasticity in multiple sclerosis2003
Jose-de-Jesus Salazar-Torres
Dr Anand Pandyan
Dr Christopher Price
Professor Michael Barnes
Professor Garth Johnson
et al.
Variations in the stretch reflex excitability due to stretch intensity (torque) in post-stroke and non-impaired volunteers2003
Dr Anand Pandyan
Frederike Van Wijck
Samantha Stark
Professor Garth Johnson
Professor Michael Barnes
et al.
A simple biomechanically based technique to measure spasticity in routine clinical practice - Results from a preliminary clinical trial2002
Dr Anand Pandyan
Frederike Van Wijck
Professor Garth Johnson
Professor Michael Barnes
Are we underestimating the clinical efficacy of botulinum toxin (type A)? Quantifying changes in spasticity, strength and upper limb function after injections of Botox (R) to the elbow flexors in a unilateral stroke population2002
Dr Anand Pandyan
Professor Christopher Price
Robert Davidson
Professor Michael Barnes
Professor Garth Johnson
et al.
Biomechanical Characterization of Reflex Activity at the Elbow—A First Step to Quantifying Spasticity2002
Professor Michael Barnes
Measurement of antibodies to Clostridium botulinum neurotoxins, types A-F, in the complexed and uncomplexed forms, in dystonia patients showing secondary resistance to therapy2002
Dr Anand Pandyan
Dr Christopher Price
Emerita Professor Helen Rodgers
Professor Michael Barnes
Emeritus Professor Garth Johnson
et al.
A quantitative investigation into the construct validity of the modified Ashworth Scale2001
Frederike Van Wijck
Dr Anand Pandyan
Emeritus Professor Garth Johnson
Professor Michael Barnes
Assessing motor deficits in neurological rehabilitation: a profile of instrument usage2001
Frederike Van Wijck
Dr Anand Pandyan
Emeritus Professor Garth Johnson
Professor Michael Barnes
Assessing motor deficits in neurological rehabilitation: Patterns of instrument usage2001
Dr Anthony Butler
Joanna Semlyen
Professor Michael Barnes
Botulinum toxin for people with dystonia treated by an outreach nurse practitioner: A comparative study between a home and a clinic treatment service2001
Professor Michael Barnes
Guidance for the preparation of neurological management guidelines by EFNS scientific task forces2001
Dr Anand Pandyan
Frederike Van Wijck
Samantha Stark
Emeritus Professor Garth Johnson
Professor Michael Barnes
et al.
Is the clinical efficacy of Botulinum Toxin Type A being underestimated in post stroke hemiplegia?2001
Professor Michael Barnes
Neurological rehabilitation in the community2001
Professor Michael Barnes
Practical aspects of using botulinum toxin type B2001
Professor Michael Barnes
Spasticity: A rehabilitation challenge in the elderly2001
Professor Michael Barnes
Task force on minimum standards for health care of people with multiple sclerosis: June 19992001
Professor Michael Barnes
Joanna Semlyen
The establishment of a community multiple sclerosis team2001
Professor Michael Barnes
Emeritus Professor Garth Johnson
Upper Motor Neurone Syndrome and Spasticity2001
Dr Barbara Chandler
Professor Michael Barnes
An epidemiological survey of the health needs of disabled people in a rural community2000
Professor Michael Barnes
Botulinum toxin (Dysport (R)) treatment of hip adductor spasticity in multiple sclerosis: a prospective, randomised, double blind, placebo controlled, dose ranging study2000
Dr Elizabeth Davis
Professor Michael Barnes
Botulinum toxin and spasticity2000
Dr Anand Pandyan
Professor Garth Johnson
Dr Christopher Price
Dr Richard Curless
Professor Michael Barnes
et al.
A review of the properties and limitations of the Ashworth and modified Ashworth Scales as measures of spasticity1999
Professor Michael Barnes
Rehabilitation after traumatic brain injury1999
Dr Tim Irvine
Professor Michael Barnes
Trust wants help in formulating system to recognise performance of salaried GPs1999